National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

This protocol is for the administration of COVID-19 mRNA vaccine BNT162b2 by appropriately trained persons to individuals in accordance with the national COVID-19 vaccination programme.

Public Health England